No products in the cart.
Description
PRODUCT DESCRIPTION:
Artesunate Tablets are a fast-acting artemisinin derivative used in the management of uncomplicated and severe malaria caused by Plasmodium falciparum and other Plasmodium species. Artesunate works by rapidly reducing the parasite biomass in the blood, offering a crucial first-line option in areas of multidrug resistance.
Offered in a wide range of strengths from 30 MG to 240 MG, these tablets provide dosage flexibility suitable for pediatric, adult, and weight-adjusted regimens.
Artesunate Tablets are often used in combination with other antimalarial agents to ensure complete parasite clearance and reduce the chances of resistance development.
Manufactured under stringent GMP guidelines, these tablets are suitable for inclusion in national malaria control programs, institutional procurement, and export to malaria-endemic regions globally.
Formulation & Presentation:
- Dosage Form: Tablets
- Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
- Available Strengths:
- Artesunate Tablets: 30 MG
- Artesunate Tablets: 60 MG
- Artesunate Tablets: 120 MG
- Artesunate Tablets: 150 MG
- Artesunate Tablets: 180 MG
- Artesunate Tablets: 210 MG
- Artesunate Tablets: 240 MG
- Route of Administration: Oral (As per physician’s discretion or therapeutic indication)
Therapeutic Indications:
- Treatment of uncomplicated malaria caused by Plasmodium falciparum
- Treatment of mixed infections involving falciparum
- Suitable for artemisinin-based combination therapies (ACTs)
Side Effects:
- COMMON:
- Headache
- Nausea or vomiting
- Dizziness
- Abdominal discomfort
- Fatigue
- SERIOUS (RARE):
- Hemolysis in G6PD-deficient patients
- Bradycardia
- Hypersensitivity reactions
- Hepatotoxicity (transient elevations in liver enzymes)
- PRECAUTIONS:
- Should be used in combination with a longer-acting antimalarial (e.g., lumefantrine, mefloquine) to prevent recurrence
- Not recommended in the first trimester of pregnancy unless no other treatment is available
- Monitor liver function in prolonged treatment
- Avoid abrupt discontinuation
Be the first to review “Artesunate Tablets in 30 MG, 60 MG, 120 MG, 150 MG, 180 MG, 210 MG, 240 MG”
TECHNICAL INFORMATION
Product Specifications
- HSN Code: To be assigned per international classification standards
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: 15 x 1 x 8 CMS
- Shelf Life: 24–36 months from date of manufacture (subject to country-specific guidelines or label specifications)
- Storage: Store below 30°C. Protect from moisture, direct sunlight, and keep out of reach of children.
Regulatory Status & Supply Information
- Regulatory Status: WHO-GMP Compliant Manufacturing. Further certifications available on request
- Export-Ready Dossiers: Available in CTD/eCTD formats
- Stability: Zone IVB Compliant
- MOQ: Negotiable based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- National Malaria Control Programs (NMCPs)
- Government Health Agencies & Ministries of Health
- NGOs & International Health Organizations (e.g., MSF, WHO procurement channels)
- Hospitals and Clinics in Endemic Areas
- Pharmaceutical Distributors targeting Africa, South-East Asia, and Latin America
- Exporters & Institutional Buyers dealing with ACT formulations and anti-malarial kits
Why Source from PHARMET?
- Oncology-focused distributors in emerging and regulated markets
- Government tenders and hospital procurement departments
- Cancer foundations and treatment support NGOs
- Pharma wholesalers serving LATAM, Africa, Southeast Asia
- Regulatory-compliant buyers seeking dossier-backed hormone therapies
Contact Details
- Email: hello@pharmet.io
- Phone/WhatsApp: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.